Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis

Patients with severe RA who do not respond to MTX treatment have a poor prognosis, with >4-fold increased mortality compared with the general population, while RA patients who respond to MTX treatment have only a moderately increased mortality rate.